Suivre
Jacques Tremblay
Jacques Tremblay
Adresse e-mail validée de crchul.ulaval.ca - Page d'accueil
Titre
Citée par
Citée par
Année
Stem and progenitor cells in skeletal muscle development, maintenance, and therapy
B Péault, M Rudnicki, Y Torrente, G Cossu, JP Tremblay, T Partridge, ...
Molecular therapy 15 (5), 867-877, 2007
7362007
Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy
JP Tremblay, F Malouin, R Roy, J Huard, JP Bouchard, A Satoh, ...
Cell transplantation 2 (2), 99-112, 1993
4161993
Intraarterial injection of muscle-derived CD34+ Sca-1+ stem cells restores dystrophin in mdx mice
Y Torrente, JP Tremblay, F Pisati, M Belicchi, B Rossi, M Sironi, ...
The Journal of cell biology 152 (2), 335-348, 2001
3532001
Human myoblast transplantation: preliminary results of 4 cases
J Huard, JP Bouchard, R Roy, F Malouin, G Dansereau, C Labrecque, ...
Muscle & nerve 15 (5), 550-560, 1992
3111992
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD
C Pichavant, A Aartsma-Rus, PR Clemens, KE Davies, G Dickson, ...
Molecular Therapy 19 (5), 830-840, 2011
2762011
Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells
D Skuk, M Goulet, B Roy, P Chapdelaine, JP Bouchard, R Roy, FJ Dugré, ...
Journal of Neuropathology & Experimental Neurology 65 (4), 371-386, 2006
2582006
Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients (vol 21, pg 1718, 2013)
DG Ousterout, P Perez-Pinera, PI Thakore, AM Kabadi, MT Brown, X Qin, ...
MOLECULAR THERAPY 21 (11), 2130-2130, 2013
232*2013
First test of a “high-density injection” protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen …
D Skuk, M Goulet, B Roy, V Piette, CH Côté, P Chapdelaine, JY Hogrel, ...
Neuromuscular Disorders 17 (1), 38-46, 2007
2312007
Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients
DG Ousterout, P Perez-Pinera, PI Thakore, AM Kabadi, MT Brown, X Qin, ...
Molecular Therapy 21 (9), 1718-1726, 2013
2302013
Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells
D Skuk, B Roy, M Goulet, P Chapdelaine, JP Bouchard, R Roy, FJ Dugré, ...
Molecular Therapy 9 (3), 475-482, 2004
2292004
Very efficient myoblast allotransplantation in mice under FK506 immunosuppression
I Kinoshita, JT Vilquin, BT GuéRette, I Asselin, R Roy, JP Tremblay
Muscle & nerve 17 (12), 1407-1415, 1994
2221994
Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice
V Brussee, F Tardif, JP Tremblay
Neuromuscular Disorders 7 (8), 487-492, 1997
2161997
High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice.
J Huard, S Verreault, R Roy, M Tremblay, JP Tremblay
Journal of Clinical Investigation 93 (2), 586, 1994
2101994
Intracellular delivery of a Tat-eGFP fusion protein into muscle cells
NJ Caron, Y Torrente, G Camirand, M Bujold, P Chapdelaine, K Leriche, ...
Molecular Therapy 3 (3), 310-318, 2001
2032001
Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation
S Goudenege, C Lebel, NB Huot, C Dufour, I Fujii, J Gekas, J Rousseau, ...
Molecular Therapy 20 (11), 2153-2167, 2012
2002012
In Vivo Migration of Transplanted Myoblasts Requires Matrix Metalloproteinase Activity
E El Fahime, Y Torrente, NJ Caron, MD Bresolin, JP Tremblay
Experimental cell research 258 (2), 279-287, 2000
1992000
FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer
JT Vilquin, B Guérette, I Kinoshita, B Roy, M Goulet, C Gravel, R Roy, ...
Human gene therapy 6 (11), 1391-1401, 1995
1951995
Prevention by anti-LFA-1 of acute myoblast death following transplantation.
B Guerette, D Skuk, F Celestin, C Huard, F Tardif, I Asselin, B Roy, ...
The Journal of Immunology 159 (5), 2522-2531, 1997
1771997
Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins
NJ Caron, SP Quenneville, JP Tremblay
Biochemical and biophysical research communications 319 (1), 12-20, 2004
1712004
Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions.
J Huard, R Roy, JP Bouchard, F Malouin, CL Richards, JP Tremblay
Transplantation proceedings 24 (6), 3049, 1992
1631992
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20